Navigation Links
ConvaTec Names Paul Moraviec President, Continence and Critical Care Business Unit and ConvaTec EMEA Region
Date:3/23/2009

SKILLMAN, N.J., March 23 /PRNewswire/ -- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that Paul Moraviec has joined the company as President of its Continence and Critical Care Business Unit and ConvaTec EMEA, which includes Europe, the Middle East and Africa.

Based in Birkerod, Denmark, Moraviec will have global responsibility for the Continence and Critical Care Business Unit, a new business unit formed following ConvaTec's integration of Unomedical, a manufacturer of single-use medical devices. Additionally, he will have responsibility for the EMEA region.

Moraviec's addition completes the new leadership structure at ConvaTec. He joins Michael Steadman, President of Wound Therapeutics, and Nino Pionati, President of Ostomy Care, who recently assumed regional responsibility for ConvaTec USA and ConvaTec Intercontinental, respectively. A fourth business unit, Infusion Devices, is headed by John Lindskog. As President, Moraviec will join the company's Executive Committee.

"Paul is a proven leader with an outstanding track record of driving growth across a number of medical device specialties, making him the ideal person to leverage the newly combined product portfolio for further penetration into the acute care and home health care settings," said David Johnson, CEO, ConvaTec. "With Paul's appointment, we now have the team in place to fully capitalize on the opportunities ahead and lead ConvaTec in achieving our goal of becoming the growth leader in each of our markets and key business areas."

Prior to joining ConvaTec, Moraviec was Chief Executive Officer of Prosurgics Limited, a surgical robotics company. Prior to this, Moraviec held the position of Vice President, International Commercial Operations for Abbott Laboratories Diabetes Care Division, where he was responsible for transforming the performance of the business to sales of $700M and a strong growth and profitability profile. In addition, Moraviec has held the positions of CEO of IIT Ltd, a UK medical device start-up company and Vice President, International Sales and Marketing for Codman, a Johnson & Johnson medical devices and diagnostics company.

About ConvaTec

ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key business divisions - Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices - ConvaTec products support health care professionals from the hospital to the community health setting. From its headquarters in Skillman, New Jersey, the company oversees more than 8,000 employees in over 90 countries serving consumers and their health care professionals on six continents. ConvaTec is owned by Nordic Capital and Avista Capital Partners. For more information, please visit www.convatec.com.

Contact

    Punnie Donohue
    ConvaTec
    Phone: 908-904-2151
    Punnie.Donohue@convatec.com


'/>"/>
SOURCE ConvaTec
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ConvaTec Announces Divestiture of Unomedical Wound Care and Ophthalmics Business
2. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
3. ConvaTec Launches New Lifestyle Magazine for People With an Ostomy
4. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
5. ConvaTec Launches SUR-FIT Natura(R) Low-Pressure Adaptor
6. Redstone Highlands Names WordWrite Communications Agency of Record
7. Cantel Medical Corp. Names Andrew Krakauer as CEO and Announces Other Corporate Appointments
8. Northern California Cancer Center Study Seeks to Improve Colon Cancer Screening in Vietnamese Communities
9. Codexis Names Sarret SVP, Corporate Development
10. Irelands Allergy Standards Limited Adds Two New U.S. Names to Line-Up of Companies Making Allergy-Certified Consumer Products
11. New Corporate Agreement with Legacy Hospital Partners, Inc. Names Broadlane Exclusive Provider of Supply Chain and Procurement Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... York (PRWEB) , ... December 05, 2016 , ... ... the ability of physical therapist assistants, under direct supervision of a licensed physical ... obtains physical therapy receives a consultation and treatment plan from a licensed physical ...
(Date:12/5/2016)... , ... December 05, 2016 , ... As renowned, board-certified ... the dangers and downsides of patients who do not do their research and undergo ... cosmetic dermatology is in the midst of a renaissance and every other month a ...
(Date:12/5/2016)... ... 2016 , ... Z-Medica, LLC, a leading developer and marketer ... College of Surgeons (ACS) to provide basic bleeding control instructor training to surgeons. ... is a pilot program that fulfills the intent of the White House’s “Stop ...
(Date:12/4/2016)... ... 03, 2016 , ... The Lymphoma Research Foundation (LRF) – ... serving the lymphoma community through a comprehensive series of education programs, outreach initiatives ... New York City, with long-time partners The Paul Foundation, on November 10, 2016. ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... wins "Best Surgical Body Shaping" at the 2016 Anti-Aging & Beauty ... France. , The Aesthetic & Anti-Aging Medicine European Congress (AMEC) brings ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... December 2, 2016 According ... Diagnostics/IVD Market by Product (Instruments, Reagents, Software), Technology ... Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to ... valued at USD 60.22 Billion in 2016. This ... of 5.5% during the forecast period (2016-2021) to ...
(Date:12/2/2016)...  The Addiction Treatment Advisory Group (ATAG), created ... Pharmacy (AMCP), has released detailed findings on how ... addiction crisis, including through improved access to naloxone ... newly released paper, "The Role of Managed Care ... issues around gaps and barriers to addiction treatment ...
(Date:12/2/2016)... , Dec. 2, 2016 Boston Scientific ... definitive agreement to acquire certain manufacturing assets and capabilities ... (TSX: NVC) advanced biological tissue business, as well as ... of $75 million in cash. The Neovasc advanced biological ... including the Boston Scientific Lotus™ Valve System. * ...
Breaking Medicine Technology: